Hypertension as a Manifestation of COVID-19 Pneumonia

COVID-19 has become a serious problem in the world due to its rapid spread and high mortality rate. Since the pandemic, various manifestations of COVID-19 pneumonia have been described, ranging from classic acute respiratory viral infections to thromboembolic manifestations as the first signs of the disease. However, the relationship between hypertension and its effect on the severity of COVID-19 is not studied well. Here we show the link between hypertension as one of the various manifestations of COVID-19 pneumonia. There is the hypothesis that the initial stage of infection is the penetration of SARS-CoV-2 into target cells with ACE2 receptors. However, some experimental studies have shown that ACE2 protects against lung damage. In this regard, it is logical to assume the presence in the pathogenesis of COVID - 19 conditions for an increase in blood pressure, which occurs in the early stages of the disease. Our result shows that hypertension can become the initial manifestation of the COVID-19 and it is very important to differentiate the disease patterns. Thus, this case clearly shows that any course of coronavirus infection could have a diverse nature of clinical forms and should have a personalized approach, taking into account risk factors and predictors, with the involvement of a multidisciplinary team to prevent long and post COVID-19 syndromes.